The genes that show the top identified patterns are involved in canonical glioblastoma signaling pathways, with addition of two novel genes, RPL5 and TRAT1. Next, we applied the model that accounts for false positives, and detected universal patterns with high coverage and low impurity, found significant by the ME test across a collection of samples from twelve different cancers. This evidence concerns the gene TRAT1 and glioblastoma.